Penn Medicine Provider
Neurology
Matthew Kevin Schindler, MD, PhD
4.9
(232)
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital
View 1 additional location

About me

  • Assistant Professor of Neurology at the Pennsylvania Hospital

Education and training

  • Medical School: Wake Forest University
  • Residency: Yale-New Haven Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

232 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
prompt, knowledgeable, caring
March 2025
5.0
5.0
he was punctual and informative about my condition with suggestions of treatment options to help my condition.
March 2025
5.0
5.0
he listened carefully to my instructions!
March 2025
5.0
5.0
liked him

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schindler is a Penn Medicine physician.

Qualifications and experience

My research

Ian Z. Ong, Dennis L. Kolson, Matthew K. Schindler Mechanisms, Effects, and Management of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC) , Biomedicines, 11(2): 2023


Abby Manning, Erin S. Beck, Matthew K. Schindler, Daniel S. Reich, Russell T. Shinohara, Andrew J. Solomon T1/ T2 Ratio from 3T MRI Improves Multiple Sclerosis Cortical Lesion Contrast , Journal of Neuroimaging , 33(3): 2023,434-445


Raghav R Mattay, Karapet Davtyan, Jeffrey D Rudie, Govind S Mattay, Dina A Jacobs, Matthew Schindler, Laurie A Loevner, Mitchell D Schnall, Michel Bilello, Alexander C Mamourian, Tessa S Cook Economic impact of selective use of contrast for routine follow-up MRI of patients with multiple sclerosis , Journal of Neuroimaging , 32(4): 2022,656-666


Hu M, Crainiceanu C, Schindler MK, Dewey B, Reich DS, Shinohara RT, Eloyan A Matrix decomposition for modeling lesion development processes in multiple sclerosis , Biostatistics, 23(1): 2022,83-100


Lou C, Sati P, Absinta M, Clark K, Dworkin JD, Valcarcel AM, Schindler MK, Reich DS, Sweeney EM, Shinohara RT Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging , NeuroImage: Clinical, 32: 2021,102796


Daboul L., O’Donnell C., Moreno-Dominguez D., Rodrigues P., Derbyshire J., Azevedo C., Bar-Or A., Caverzasi E., Calabresi P., Cree B., Freeman L., Henry R., Longbrake E., Oh J., Papinutto N., Pelletier D., Samudralwar R., Schindler M., Sotirchos E., Sicotte N., Ontaneda D. Gadolinium Improves Detection of Central Vein Lesions in MS Using 3T FLAIR* , Mult. Scler. J. : 2021


Arnold TC, Tu D, Okar SV, Nair G, By S, Kawatra KD, Robert-Fitzgerald TE, Desiderio LM, Schindler MK, Shinohara RT, Reich DS, Stein JM Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions , Neuroimage: Clinical, 35(103101): 2022


Ontaneda D, Sati P, Raza P, Kilbane M, Gombos E, Alvarez E, Azevedo C, Calabresi P, Cohen JA, Freeman L, Henry RG, Longbrake EE, Mitra N, Illenberger N, Schindler M, Moreno-Dominguez D, Ramos M, Mowry E, Oh J, Rodrigues P, Chahin S, Kaisey M, Waubant E, Cutter G, Shinohara R, Reich DS, Solomon A, Sicotte NL Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial , Neuroimage: Clinical: 2021


Irene Cortese, Erin S. Beck, Omar Al-Louzi, Joan Ohayon, Frances Andrada, Ikesinachi Osuorah, Jen Dwyer, B. Jeanne Billioux, Nigar Dargah-zada, Matthew K. Schindler, Kyle Binder, Lauren Reoma, Gina Norato, Yoshimi Enose-Akahata, Bryan Smith, Maria Chiara Monaco, Eugene O. Major, Steve Jacobson, David Stroncek, Steven Highfill, Sandhya Panch, Daniel S. Reich, John Barrett, Avindra Nath, Pawel Muranski BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study. , Lancet Neurology: 2021


Valcarcel AM, Muschelli J, Pham DL, Martin ML, Yushkevich P, Brandstadter R, Patterson KR, Schindler MK, Calabresi PA, Bakshi R, Shinohara RT TAPAS: A threshold approach for probability map automatic segmentation in multiple sclerosis , Neuroimage: Clinical, 27: 2020,102256